Space‑pharma breakthrough: Varda Space drug crystals funding boost
IntroductionIn a significant milestone for space‑based biotechnology, Varda Space Industries has secured $187 million in Series C funding, bringing its total venture capital raised to approximately $329.4 million. This round marks a substantial validation for the startup’s mission to manufacture pharmaceutical crystals in microgravity aboard rockets and capsules. The funding, led by Natural Capital and Shrug…